Occult hepatitis C: how convincing are the current data?
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisCellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?Occult HCV Infection: The Current State of KnowledgeA New Twist to a Chronic HCV Infection: Occult Hepatitis CThe place of immunotherapy in the management of HCV-induced vasculitis: an updateOccult HCV Infection: An Unexpected Finding in a Population Unselected for Hepatic DiseaseDeep sequencing analysis of HCV NS3 resistance-associated variants and mutation linkage in liver transplant recipientsTrace amounts of sporadically reappearing HCV RNA can cause infectionMembranoproliferative glomerulonephritis and mixed cryoglobulinemia after hepatitis C virus infection secondary to glomerular NS3 viral antigen deposits.Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity.Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease.Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patientsInvestigation of residual hepatitis C virus in presumed recovered subjects.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis.Occult Hepatitis C Virus Infection in Hemodialysis Patients; Single Center StudyOccult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosisSequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection?DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target.Hepatitis C virus late relapse after sustained virologic response from interferon and ribavirin treatment as confirmed by RNA sequencing.Impact of HCV genetic differences on pathobiology of disease.Hepatitis C virus infection and kidney transplantation in 2014: what's new?Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.Persistent replication of a hepatitis C virus genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B in a New World monkey.Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.Is psychosocial and cognitive dysfunction misattributed to the virus in hepatitis C infection? Select psychosocial contributors identified.Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection.Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies.Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.Sustained virologic response: is this equivalent to cure of chronic hepatitis C?Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.Screening for occult hepatitis C virus infection: Does it need special attention?Expression of CD81, SR-BI and LDLR in lymphocytes and monocytes from patients with classic and occult hepatitis C virus infection.
P2860
Q21132564-722A0107-6C77-436A-A538-3598275773E6Q26749249-226A2503-9AC7-42B0-B616-44EFC3DB67ACQ26770595-BDFAEC93-7FC5-4D78-960D-03AFFF969598Q26798189-35E86C43-BD82-4811-9A02-A10AC5C42835Q27015124-DB9F033E-123B-49D1-A419-7A0BE707E7E0Q27490419-009084F4-A487-4633-BD12-715247588D7CQ28534965-0B87A619-A21F-4508-970B-39DCE789426FQ33944273-71661EA1-3C55-4CC9-A366-08AB9849D993Q34128722-EB7C9EA5-C9A9-40D1-B33C-3CA2AAA3B5CAQ34166233-2CB67FDA-1048-438E-B0B0-BDDB22AB63EBQ34395796-3B661212-1EAA-450F-B783-07AF37C671DEQ34701250-2E15781E-72AD-4ED0-A21D-912EA5CA07ACQ35911576-38730E74-01B2-4C81-9514-3387CA5A7C3AQ36073739-DA59E84A-4A74-410E-9A28-A37868F30506Q36301391-93145D57-75B6-4CB8-B3AC-38B8D29763B1Q36497984-79D6C5FD-BF98-4584-A145-40D98A0875C6Q37204495-DA31DB01-FE47-43E2-A4F2-E5C29D000B46Q37395341-02EFE7A1-88A4-46CE-88FD-68400FB96D23Q37519635-F3E1C2B3-6B9E-407E-97A4-0052B5DEB948Q37546612-FCB11299-0BE5-441F-9889-730E63B9D81BQ37929753-C1D027F1-51BF-4472-9501-F1C9A106E144Q38236820-4698C690-FD14-44A4-B088-966C6BD28D8CQ38738490-2749690C-8DEB-44C1-A5CC-2CCC43A10C87Q40244787-2FD5EBFA-7B19-46D1-B2B2-1408AE566462Q40329699-C4B41D3F-E2D3-4BEF-B0EC-97BFFEA43431Q40454523-FCB5C962-4B9F-44E3-8184-E53C0EB81743Q40598150-C438AA3A-7A03-4799-BE4A-1B020506EEEDQ40679240-F43D56EF-7A71-4391-8126-A64388F18D90Q40692627-44846C1D-BC22-40FE-89AD-AD43840C2DA4Q40766567-BCF70D6C-6EA6-424D-BA5B-4AD4797E8A79Q40809063-1917AFA2-A006-4DB0-93D9-8D4CC30D9C29Q42262339-CA946268-2AA5-4AAA-A771-B3B8F7DB1C54Q42982421-FFEAA1D3-2584-471D-B9B0-EDF972ED59A0Q43040462-7A4DE25D-4486-4ACB-B0CC-163F236AEF07Q45343938-442A8493-DDD7-4B20-9156-11DD548B3AC7Q45354663-FD9C711F-109F-4E80-83C5-655120D3CDE9
P2860
Occult hepatitis C: how convincing are the current data?
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Occult hepatitis C: how convincing are the current data?
@ast
Occult hepatitis C: how convincing are the current data?
@en
type
label
Occult hepatitis C: how convincing are the current data?
@ast
Occult hepatitis C: how convincing are the current data?
@en
prefLabel
Occult hepatitis C: how convincing are the current data?
@ast
Occult hepatitis C: how convincing are the current data?
@en
P2860
P356
P1433
P1476
Occult hepatitis C: how convincing are the current data?
@en
P2093
Martin-Walter Welker
P2860
P304
P356
10.1002/HEP.22706
P407
P577
2009-02-01T00:00:00Z